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Background. Coronary artery ectasia (CAE) is deﬁned as localized or diﬀuse dilation of the coronary arteries. There are scarce
data about the role of dendritic cells in CAE development. In this study we investigated the activation markers on the surface of
monocyte-derived dendritic cells (mDCs) in coronary artery disease (CAD) patients with or without CAE. Method. The study
consisted of 6 patients who had obstructive CAD with CAE, 6 CAD patients without CAE and 6 subjects with angiographically
normal coronary arteries. mDCs were cultivated from peripheral blood monocytes. Surface activation markers were detected by
ﬂow cytometry. Results. CAD patients with CAE were detected to have signiﬁcantly higher mean ﬂuorescence intensities of CD11b,
CD11c, CD54 , CD83, CD86 and MHC Class II molecules on mDCs in comparison to CAD patients without CAE and normal
controls (P<. 001 for all). A signiﬁcant positive correlation was found between the number of vessels with CAE and the levels
of CD11c, CD86, and MHC Class II molecules. Conclusion. mDCs display an increased cell surface concentration of activation
molecules in CAD patients with CAE compared to patients with CAD alone. DC activation may play an important role for CAE
development in patients with CAD.
1.Introduction
Coronaryarteryectasia(CAE)hasbeendeﬁnedassegmental
or diﬀuse luminal dilatation of the coronary arteries in
coronary angiography [1]. CAE is a rare ﬁnding among
coronary artery anomalies and considered to be congenital
in 10–20% of the cases while the remaining are acquired in
origin [2]. The common coexistence of CAE with coronary
artery disease (CAD) suggests that it may be a variant of
atherosclerosis [2, 3] .H o w e v e ri ti sn o tc l e a rw h ys o m e
patients with obstructive CAD develop CAE whereas most
do not.
Dendritic cells (DCs) are potent antigen presenting
and immune modulating cells with the unique ability to
initiate a primary immune response to certain antigens
by the activation of T lymphocytes [4, 5]. To acquire the
ability to contact and activate T cells, DCs must undergo
a maturation process with the upregulation of antigen
presenting molecules including MHC class I and class II,
adhesion molecules (CD11a, CD11b, CD54, CD50, CD58)
and costimulatory molecules (CD40, CD80, CD86) [4–
6]. In addition to these relatively well-known cell surface
molecules; CD83 which is the hallmark of mature DCs and
CD11c expressions were also reported to have functions
in the regulation of antigen presentation and enhancement
of T cell activation in the recent reports [7, 8]. During
the development of an adaptive response, T cells form
direct contacts with DCs and respond to peptide antigen
displayed on MHC Class II and Class I molecules present
on DC surfaces. In DC/T cell interactions, the presence of
costimulatory molecules is required for T cell activation and
diﬀerentiation into eﬀector cells [6].2 Mediators of Inﬂammation
SofarthepresenceofDCwasdescribedinatherosclerotic
plaquesofcarotidarteries,aortas,andstenoticaortacoronary
vein bypass grafts [9]. The colocalization of DC and T
cells as well as the expression of MHC-II and costimulatory
molecules on DCs in atherosclerotic plaques suggest that DC
initiate an antigen-spesiﬁc immune response contributing to
the progression of atherosclerosis [9–11]. Until now research
on the pathogenesis of CAE has also focused on chronic
transmural inﬂammation [2, 3]. Recently we have shown
increased expression of monocyte and lymphocyte adhesion
molecules in isolated CAE [12]. Given the pivotal function of
DCs in initiating T lymphocyte responses in atherosclerosis
and the knowledge that peripheral blood monocytes can be
diﬀerentiated into DCs by exposure to inﬂammatory factors
[13]; in the present study we investigated the expression
levels of MHC Class II, CD54, CD11b, CD11c, CD83, and
CD86 on the surface of monocyte-derived DCs (mDCs) in
normalsubjectsandCADpatientswithorwithoutCAE.Our
aim was to evaluate the role of DCs in CAE development.
2.MaterialandMethods
2.1. Study Population. The study was designed as a case
control prospective study. The study population was selected
from a series of 256 consecutive patients who underwent
coronary angiography in our hospital between April 2006
and September 2006 due to the presence of chest pain or
positive or equivocal results of noninvasive screening tests
for myocardial ischemia. Out of 256 patients, 6 consecutive
patients with obstructive CAD and CAE (Group 1, 4 male,
mean age: 50.1 ± 4.0 years) and accepted to participate
our study after giving informed consent, were identiﬁed
a n dc o m p a r e dw i t ha g ea n ds e xm a t c h e d6c o n s e c u t i v e
subjects with obstructive CAD alone (Group 2, 4 male,
mean age: 51.1 ± 4.5) and 6 consecutive subjects who had
angiographically shown normal coronary arteries (Group
3, 4 male, mean age: 51.1 ± 4.2). Obstructive CAD was
deﬁned as the stenosis of epicardial coronary artery >50%
angiographically.
Exclusion criteria were the presence of previous myocar-
dialinfarction,acutecoronarysyndromes,anyinﬂammatory
or immunologic disease, active local or systemic infection,
history of recent infection (<3 months), left ventricular
dysfunction, left ventricular hypertrophy, cardiomyopathies,
congenital heart disease, valvular heart disease, any abnor-
mality in thyroid function test, arrhythmias and statin
use within the last 6 months. Besides, leukocyte count,
erythrocyte sedimentation rate and ﬁbrinogen levels were
normal in all patients and control subjects.
2.2. Coronary Angiography. Coronary angiography was rou-
tinely performed without the use of nitroglycerin. Selective
coronary angiography was performed by means of Jud-
kins technique in multiple projections. We used Iohexol
(Omnipaque, Nycomed Ireland Cork, Ireland) as contrast
agent during coronary angiography in all patients and
control subjects. Coronary angiograms were analyzed by
two blinded interventional cardiologists without knowledge
of the clinical status and laboratory measurements of the
subjects. The deﬁnition of CAE was that used in the
CoronaryArterySurgeryStudy(CASS)[1]. According to the
angiographic deﬁnition of CASS, a vessel is considered to be
ectasic when its diameter is ≥1.5 times that of the adjacent
normal segment in segmental ectasia. When there was no
identiﬁable adjacent normal segment, the mean diameter of
the corresponding coronary segment in the control group
served as normal values. The number of epicardial coronary
arteries with ectasia was analysed by use of a computerized
quantitative coronary angiography analysis system (Philips
BH 5000, Netherland).
2.3. Generation of Dendritic Cells and Cell Culture. Hep-
arinized blood samples of the groups were drawn after
coronary angiography from an antecubital vein with a 19-
gaugeneedlewithoutvenousstasisinthefastingstate.mDCs
were generated according to an established method with
minor modiﬁcations [13]. Peripheral blood mononuclear
cells were isolated by density gradient centrifugation with
Ficoll Hypaque 1077 density (PAA laboratories GMBH,
Austria). Monocytes were isolated from peripheral blood
mononuclear cells by their adherence to plastic. During 9
days of cell culture in the presence of RPMI-1640 medium
(Sigma Chemical, Germany) supplemented with 10% FCS
(Sigma Chemical) monocytes were diﬀerentiated into DC.
2.4. Flow Cytometric Analysis. The technique of ﬂow cytom-
etry involves the staining of blood cells with ﬂuorescence
tagged antibodies targeted to speciﬁc cell surface associated
antigens. This is followed by quantiﬁcation of ﬂuorescence
intensity in the cell population of interest as a measure
of the speciﬁc antigen abundance and by determination
of percentage of cells displaying ﬂuorescence intensity
beyond a threshold [4]. DC were incubated with the mouse
antihuman, ﬂuorescein isothiocyanate (FITC)-conjugated
antibodies against CD14, CD11b, CD11c, CD54, CD83,
CD86, and MHC Class II-phycoerythrin (Beckman Coulter,
CA, USA) for 15 minutes at room temperature. After
immunoﬂuorescence staining, cells were analyzed by Epics
Proﬁle II ﬂow cytometer (Beckman Coulter). Appropriate
isotype-matched immunoglobulins (Beckman Coulter) were
used as negative controls. The mean ﬂuorescence intensity
(MFI) was analyzed for at least 5000 cells per sample [4].
2.5.StatisticalAnalysis. Statisticalanalysiswasmadebyusing
SPSS for windows 11.0. Continuous variables were expressed
as mean ± SD and categorical variables were expressed as
percentage.Comparisonoftheexpressionlevelsofactivation
markers on mDCs among the groups was performed using
one-way anova test. Tukey HSD multivariate analysis was
used to determine among which groups the activation
marker levels were diﬀerent. The comparison of categorical
variables between the groups were assessed by Fisher’s
exact or chi-square tests where appropriate. The association
between the levels of activation markers and the number of
ectasic vessels was calculated by Spearman’s rho correlationMediators of Inﬂammation 3
Table 1: Clinical and coronary angiographic ﬁndings of the study population.
NCA (n = 6)
∗ CAD (n = 6) CAD + CAE (n = 6)
Age (years) 51.1 ±4.25 1 .1 ±4.55 0 .1 ±4.0
Gender (male/female) 4/2 4/2 4/2
Hypertension 2/6 (33.3%) 2/6 (33.3%) 2/6 (33.3%)
Diabetes mellitus 2/6 (33.3%) 2/6 (33.3%) 2/6 (33.3%)
Hyperlipidemia 3/6 (50%) 3/6 (50%) 3/6 (50%)
Cigarette smoking 4/6 (66.7%) 4/6 (66.7%) 4/6 (66.7%)
CAE distribution
LAD — — 4/6 (66.7%)
Cx — — 5/6 (83.3%)
RCA — — 4/6 (66.7%)
One vessel — — 1/6 (16.7%)
Two vessel — — 2/6 (33.3%)
Three vessel — — 3/15 (50%)
∗Indicates no signiﬁcant diﬀerence between all groups for all parameters; NCA: normal coronary artery; CAD: coronary artery disease; CAE: coronary artery
ectasia; LAD: left anterior descending artery; Cx: circumﬂex artery; RCA: right coronary artery.













Figure 1: The graphic showing the mean expression levels of the
activation markers on monocyte-derived dendritic cells in each
study group. NCA: the group with normal coronary arteries. CAD:
the group with coronary artery disease. CAD
+: the group with
coronary artery disease and coronary artery ectasia. MFI: mean
ﬂuorescence intensity.
coeﬃcient. A P-value of <.05 was considered statistically
signiﬁcant.
3. Results
There was statistically no signiﬁcant diﬀerence between
the groups with respect to age, gender, body mass index,
hypertension, diabetes mellitus, cigarette smoking and
hyperlipidemia (P>. 05). The distribution of obstructive
CAD was also comparable between CAD patients with or
without CAE [single vessel involvement 13.3%, two-vessel
involvement 26.7%, and three vessel involvement 60% for
both groups] (P>. 05 for all). The patients in group 1 had
diﬀuse CAE involving the left anterior descending artery in
4 (66.7%), the left circumﬂex artery in 5 (83.3%) and the
right coronary artery in 4 patients (66.7%). One-vessel, two-
vessel, and three-vessel ectasia were found to be present in
1 (16.7%), 2 (33.3%), and 3 (50%) patients, respectively.
Therefore most of the patients (83.3%) had multivessel CAE.
Clinical and coronary angiographic characteristics of the
study population were presented in Table 1.
CAD patients with CAE were detected to have signif-
icantly higher levels of certain activation markers such as
CD11b (44.5 ±5.0v e r s u s3 0 .0 ±3.8a n d2 0 .9 ±3.6), CD11c,
(96.3 ± 10.9v e r s u s6 6 .1 ± 6.4a n d5 0 .4 ± 5.7) CD54 (45.6 ±
6.7v e r s u s3 1 .1 ± 4.9a n d2 0 .8 ± 3.2), CD83 (44.6 ± 6.1
versus 30.8 ± 2.4a n d2 5 .6 ± 2.8), CD86 (50.7 ± 5.0v e r s u s
39.2 ± 4.1a n d2 9 .5 ± 4.1) and MHC Class II (112.4 ±
11.3v e r s u s7 3 .1 ± 9.5a n d5 4 .5 ± 4.5) molecules on the
surface of mDCs in comparison to CAD patients without
CAE and normal subjects with angiographically normal
coronary arteries (Figure 1). MFI of CD14 on mDCs did not
signiﬁcantly diﬀer among Group 1 (13.3 ± 3.1), Group 2
(12.9 ± 2.6), and Group 3 (14 ± 2.9) (P>. 05). Furthermore
we detected a signiﬁcant positive correlation between the
number of the vessels with CAE and the levels of CD11c
(Figure 2), CD86 (Figure 3), and MHC Class II molecules
(Figure 4).
4. Discussion
The main ﬁndings of the present study are (1) the expression
of CD11b, CD11c, CD54, CD83, CD86, and MHC Class
II molecules in CAD patients with CAE were higher than
control subjects with CAD alone and normal coronary
arteries; (2) there was a correlation between the levels of
CD11c, MHC Class II, CD86, and the number of coronary
vessels with CAE. To our knowledge this is the ﬁrst study
that demonstrate the role of mDCs for CAE development in
patients with CAD.
CAE has been deﬁned as localized or diﬀuse nonob-
structive lesions of the epicardial coronary arteries with a
luminal dilatation exceeding the 1.5 fold of normal adjacent
segment or vessel diameter [1]. It has been suggested that the
pathogenesis of abdominal aortic aneurysm and CAE is sim-




















Figure 2: The graph showing the relationship between the number
of ectatic vessels and the expression level of CD11c molecule. r:
Spearman’s rho correlation coeﬃcient. MFI: mean ﬂuorescence
intensity.
of medial layer of the vessel has a prominent role [2, 14].
Recently we have reported an increase in the plasma levels
of tumor necrosis factor-alpha and interleukin-6 in patients
with isolated CAE indicating an inﬂammatory process in
the coronary circulation [15]. Furthermore Turhan H et al.
showed that levels of soluble CAMs; intercellular adhesion
molecule-1, vascular cell adhesion molecule-1 and E-selectin
were increased in patients with isolated CAE in comparison
to patients with obstructive CAD and suggested that a
more extensive vascular wall inﬂammation may have a role
in the development of isolated CAE [16]. Although the
role of inﬂammation was demonstrated in the pathogenesis
of CAE, since inﬂammation takes part both in CAE and
atherosclerosis development, it is still not clear why some
patients with obstructive CAD develop CAE whereas most
do not.
DCs are a component of the proposed vessel-associated
lymphoid tissue and are found in the intima and adventitia
of susceptible arteries before atherosclerotic lesion develop-
ment [6, 17]. In atherosclerotic plaques, the number of DCs
increase related to the activation of residing intimal DCs and
invasion of adventitial DCs to the plaque [6]. Monocytes
that inﬁltrate the intima from the very early stages of
atherosclerosis may diﬀerentiate into DCs and contribute
to an increased DC population as well [6, 13, 18]. Recent
ﬁndingssuggestthatDCsplayaroleinplaquedestabilization
through activation of T cells [6]. Yilmaz et al. found that
up to70% of DCs in the shoulders of vulnerable carotid
plaques express increased level of DC activation marker
CD83 [9]. Ranjit et al. reported that CD86 was upregulated






















Figure 3: The graph showing the relationship between the number
of ectatic vessels and the expression level of CD86 molecule. r:
Spearman’s rho correlation coeﬃcient. MFI: mean ﬂuorescence


















Figure 4: The graph showing the relationship between the number
of ectatic vessels and the expression level of MHC Class II. r:
Spearman’s rho correlation coeﬃcient. MFI: mean ﬂuorescence
intensity. MFI: mean ﬂuorescence intensity.
donors [19]. Antigen processing, presentation, and T cell
priming eﬃcacy were shown to be maintained in DCs with
increased expression of CD11c under hypercholesterolemicMediators of Inﬂammation 5
conditions associated with atherosclerosis [8]. Although the
role of DCs in atherosclerosis were evaluated in various
studies, there is limited data about DCs in CAE which has
been suggested as a variant of atherosclerosis.
In the present study we have found increased expression
of adhesion, costimulatory and antigen presenting molecules
on the surface of mDCs in CAD patients with CAE
compared to patients with CAD alone as well as normal
subjects. Activated DCs have been shown to exhibit large
numbers of adhesion molecules such as CD11b, CD54 which
contribute to their ability to adhere to injured endothelium,
transmigrate and also interact with T lymphocytes [5, 20,
21]. This interaction is accompanied by the increase in the
expression of MHC and costimulatory molecules and the
production of cytokines leading to their enhanced ability to
p r i m eTl y m p h o c y t e s[ 4–6]. Therefore increased expression
of the surface markers of mDCs with a positive correlation
between CD11c, CD86, and MHC Class II molecules and the
number of ectasic vessels observed in the present study may
support the concept that a more severe and extensive chronic
inﬂammation modulated by DCs takes place in the coronary
circulation of CAD patients with CAE in correlation with the
widespread involvement of CAE.
Numerous studies have demonstrated that aneurysm
tissue contains high levels of matrix metalloproteinases
(MMP) which causes degradation of the extracellular matrix
leading to weakening and dilatation of the aortic wall [22].
The histopathological examinations of the coronary arteries
in small number of cases with CAE were reported to include
inﬂammatory cells in the medial layer comprising chieﬂy
macrophages which were shown to have immunoreactivity
against MMP [23, 24]. Recently we reported increased
expression of monocyte adhesion molecules in patients
with isolated CAE that may be associated with the medial
destruction of the vessel wall and CAE formation in
agreement with microscopic examinations [12]. Moreover
Dogan et al. reported high plasma levels of MMP-3, MMP-
9 and interleukin-6 in CAE patients and suggested that
inﬂammation enhanced MMP secretion in the coronary
circulation may cause CAE formation [25]. DCs were also
shown to secrete MMP to the same extent as macrophages
[26, 27]. Hence our ﬁnding of signiﬁcantly increased DC
activation in CAD patients with CAE compared to patients
with CAD alone may be associated with weakening of the
coronary artery wall by MMP of which secretion may be
enhanced by DCs.
5. Study Limitations
It is conceivable that the small number of patients limits the
power of our observations. The small number of patients
in the present study reﬂects the small incidence of patients
withCAE.Thephenotypiccharacteristicsofthemostmature
DCs have been suggested to be complete loss of CD14,
and increased expression of CD83, CD86, and MHC Class
II receptor [28]. DCs generated by our methods had low
expression of CD14, moderate expression of CD83, CD86,
and MHC Class II and thus would be considered as relatively
immature DCs compared to DCs generated by the other
methods [4, 28, 29]. However since mDCs of the three
groups were cultivated in the same environment under the
same conditions, the signiﬁcantly diﬀerent activation marker
levels on the surface of mDCs among the groups detected in
our study may be of importance. Further studies with larger
samplesusingadditionalstimulatorsforimprovementofDC
maturation which also investigate the correlation between
DC activation and MMP secretion are needed to ﬁrmly
establish our results.
6. Conclusion
The present study indicates that mDCs display an increased
cell surface concentration of adhesion, costimulatory, and
antigen presentation molecules with respect to their activa-
tion in CAD patients with CAE compared to patients with
CAD alone and normal subjects. DC activation may play
an important role for CAE development in patients with
obstructive CAD.
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